1. Home
  2. CLIK vs PIRS Comparison

CLIK vs PIRS Comparison

Compare CLIK & PIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLIK
  • PIRS
  • Stock Information
  • Founded
  • CLIK 2017
  • PIRS 2001
  • Country
  • CLIK Hong Kong
  • PIRS United States
  • Employees
  • CLIK N/A
  • PIRS N/A
  • Industry
  • CLIK
  • PIRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLIK
  • PIRS Health Care
  • Exchange
  • CLIK NYSE
  • PIRS Nasdaq
  • Market Cap
  • CLIK 21.9M
  • PIRS 22.2M
  • IPO Year
  • CLIK 2024
  • PIRS N/A
  • Fundamental
  • Price
  • CLIK $1.57
  • PIRS $16.42
  • Analyst Decision
  • CLIK
  • PIRS
  • Analyst Count
  • CLIK 0
  • PIRS 0
  • Target Price
  • CLIK N/A
  • PIRS N/A
  • AVG Volume (30 Days)
  • CLIK 698.1K
  • PIRS 6.0K
  • Earning Date
  • CLIK 11-14-2024
  • PIRS 11-12-2024
  • Dividend Yield
  • CLIK N/A
  • PIRS N/A
  • EPS Growth
  • CLIK N/A
  • PIRS N/A
  • EPS
  • CLIK 0.06
  • PIRS N/A
  • Revenue
  • CLIK $5,657,132.00
  • PIRS $20,872,000.00
  • Revenue This Year
  • CLIK N/A
  • PIRS N/A
  • Revenue Next Year
  • CLIK N/A
  • PIRS N/A
  • P/E Ratio
  • CLIK $24.48
  • PIRS N/A
  • Revenue Growth
  • CLIK 36.12
  • PIRS N/A
  • 52 Week Low
  • CLIK $1.23
  • PIRS $6.20
  • 52 Week High
  • CLIK $4.39
  • PIRS $23.20
  • Technical
  • Relative Strength Index (RSI)
  • CLIK N/A
  • PIRS 54.32
  • Support Level
  • CLIK N/A
  • PIRS $16.09
  • Resistance Level
  • CLIK N/A
  • PIRS $16.96
  • Average True Range (ATR)
  • CLIK 0.00
  • PIRS 0.22
  • MACD
  • CLIK 0.00
  • PIRS 0.06
  • Stochastic Oscillator
  • CLIK 0.00
  • PIRS 82.80

About CLIK CLICK HOLDINGS LIMITED

Click Holdings Ltd is a human resources solutions provider, specializing in offering comprehensive human resources solutions. It is focused on talent sourcing and the provision of temporary and permanent personnel to customers and also in placing professional accountants and company secretaries, registered nurses and healthcare workers as well as other blue-collar workers, for direct hire and contract staffing roles. The Company operates in three segments, 1) professional solution services, 2) nursing solution services and 3) logistic and other solution services. Maximum revenue is generated from Professional solution services and Hong Kong.

About PIRS Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.

Share on Social Networks: